Turn Therapeutics (TTRX) Operating Expenses (2024 - 2026)

Turn Therapeutics has reported Operating Expenses for 3 years, with the latest figure at $1.2 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 223.68% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $5.7 million (changed N/A YoY), and the FY2025 full-year result was $5.9 million, up 226.0% from the prior year.
• Operating Expenses for Q1 2026 stood at $1.2 million, down from $2.2 million in the prior quarter.
• The five-year high for Operating Expenses was $2.2 million in Q4 2025, with the low at $328957.0 in Q4 2024.
• Average Operating Expenses over 3 years is $1.1 million, with a median of $959567.5 recorded in 2024.
• Peak annual rise in Operating Expenses reached 566.83% in 2025, while the deepest fall reached 184.34% in 2025.
• Tracing TTRX's Operating Expenses over 3 years: stood at $328957.0 in 2024, then jumped by 566.83% to $2.2 million in 2025, then plunged by 43.19% to $1.2 million in 2026.
• The last three Operating Expenses figures came in at $1.2 million (Q1 2026), $2.2 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.

Peer Comparison